Risk-Takers Will Like Tharimmune Inc (NASDAQ: THAR).
In the last trading session, 2.12 million shares of the Tharimmune Inc (NASDAQ:THAR) were traded, and its beta was 1.31. Most recently the company’s share
In the last trading session, 2.12 million shares of the Tharimmune Inc (NASDAQ:THAR) were traded, and its beta was 1.31. Most recently the company’s share
In today’s recent session, 8.34 million shares of the Tharimmune Inc (NASDAQ:THAR) have been traded, and its beta is 1.40. Most recently the company’s share
Tharimmune Inc (NASDAQ:THAR)’s traded shares stood at 1.26 million during the last session, with the company’s beta value hitting 1.35. At the close of trading,
In the latest trading session,, 1.13 million Tharimmune Inc (NASDAQ:THAR) shares changed hands as the company’s beta touched 1.35. With the company’s most recent per
During the last session, Tharimmune Inc (NASDAQ:THAR)’s traded shares were 1.11 million, with the beta value of the company hitting 1.51. At the end of
During the last session, Tharimmune Inc (NASDAQ:THAR)’s traded shares were 61.19 million, with the beta value of the company hitting 1.51. At the end of
In today’s recent session, 45.82 million shares of the Tharimmune Inc (NASDAQ:THAR) have been traded, and its beta is 1.51. Most recently the company’s share
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.